The viral illness kills more people in the city than HIV, but antiviral medications may be helping cut its transmission.

Research conducted by a local hospital has found that hepatitis B patients with a simple fatty liver have a lower mortality ...

A Seattle biotech company is working on a tweak to gene expression that could shut down hepatitis B (HBV), one of the viruses ...

In Europe, the introduction of HBV vaccination has markedly reduced the incidence of acute HBV ... [1] Since 1992, the inclusion of hepatitis B vaccination has been recommended by the WHO in ...

With several drugs in use that inhibit the hepatitis B virus polymerases (nucleos(t)ide analogues (or NUCs)), some argue that new direct-acting antiviral drugs, and new NUCs in particular ...

Chronic hepatitis B (CHB) remains a significant global health challenge, and effective antiviral therapies are essential for long-term management. This study aimed to evaluate the real-world ...

Viral infections such as hepatitis A and E cause acute hepatitis, whereas Hepatitis B and C cause chronic infections. Other viral infections, such as dengue, Herpes simplex etc, also can cause ...

Viral hepatitis is a major danger to public health. According to WHO’s 2024 Global Hepatitis Report, viral hepatitis deaths increased from 1.1 million in 2019 to 1.3 million in 2022, rates now similar ...

Savage resident Edwin Tan spent his summer carrying a message across the triathlon finish line. Tan, 29, lives with chronic hepatitis B. He said there isn’t a lot of public ...

Collaboration with South Korean university advocates early antiviral treatment for hepatitis B | Feb. 5, 2025 13:09 ...

Existing treatment criteria for chronic hepatitis B virus (HBV) infection are mainly based on data from observational studies, such as the REVEAL study from Taiwan, which was initiated in the early ...

After 37 years of pioneering health journalism, community engagement, and empowerment through information, we have now ceased operations. This website will be accessible until September 2025, with all ...